DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 94 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Which IPOs are open now in India?

The current list of open, upcoming and recently listed mainboard and SME IPOs — with price band, lot size, subscription dates and listing details — is on the DocStoX IPO calendar at https://docstox.com/ipos.

What is an IPO price band and lot size?

The price band is the range within which you can bid for IPO shares; the lot size is the minimum number of shares per application. You apply in multiples of the lot size within the band. DocStoX lists both for every open IPO.

What is the difference between a mainboard and an SME IPO?

Mainboard IPOs are larger companies listed on the main NSE/BSE boards with lower lot sizes and broad retail access; SME IPOs are smaller companies on the SME platforms with larger minimum investment and higher risk.

All filings

Avience Biomedicals Ltd.

RHP · filed 18 Jun 2026

SEBI cleared

Read the full filing View AVIENCE

Avience Biomedicals Ltd. is a company with a return on equity of 49.89%. The draft prospectus details the company's business operations and financial trajectory. The offer structure includes a fresh issue and an offer for sale. The material risks associated with the company are outlined in the document.

Partial analysis — some sections could not be read from the document (found: cover, objects, price_basis).

What stands out

Healthy return on equity. ROE of 49.9%.

How the offer is structured

Part finances the capital expenditure towards setting up of a new manufacturing unit at industrial plot no. 70, Sector 28 in the Medical Device Park under the Yamuna Expressway Industrial Development Authority (YEIDA), Gautam Buddha Nagar, Uttar Pradesh₹14.0 Cr
Funding the working capital requirement of our Company₹8.3 Cr
General Corporate Purposes₹4.0 Cr

No dimension score is published for this filing. Too few sections could be read from the document to score it without guessing, and a score built on two fields would say more about our extraction than about the company.